Evidence map›Paper›PMID 25948514›Full record

ArticleEuropean journal of nutrition2016

Modulation of cholesterol-related gene expression by ergosterol and ergosterol-enriched extracts obtained from Agaricus bisporus.

Alicia Gil-Ramírez, Víctor Caz, Roberto Martin-Hernandez, Francisco R Marín, Carlota Largo, Arantxa Rodríguez-Casado, María Tabernero, Alejandro Ruiz-Rodríguez, Guillermo Reglero, Cristina Soler-Rivas

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Ergosterol Alleviates Kidney Injury in Streptozotocin-Induced Diabetic Mice.Evidence-based complementary and alternative medicine : eCAM · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Alicia Gil-RamírezDepartment of Production and Characterization of Novel Foods, CIAL - Research Institute in Food Science (UAM+CSIC), Universidad Autónoma de Madrid, C/Nicolas Cabrera 9, Campus de Cantoblanco, 28049, Madrid, Spain.
Víctor CazDepartment of Experimental Surgery, Research Institute Hospital La Paz (IdiPAZ), Paseo de la Castellana 261, 28046, Madrid, Spain.
Roberto Martin-HernandezIMDEA Food Institute, Pabellón Central del Antiguo Hospital de Cantoblanco (Edificio no 7), Crta. de Cantoblanco no 8, 28049, Madrid, Spain.
Francisco R MarínDepartment of Production and Characterization of Novel Foods, CIAL - Research Institute in Food Science (UAM+CSIC), Universidad Autónoma de Madrid, C/Nicolas Cabrera 9, Campus de Cantoblanco, 28049, Madrid, Spain.
Carlota LargoDepartment of Experimental Surgery, Research Institute Hospital La Paz (IdiPAZ), Paseo de la Castellana 261, 28046, Madrid, Spain.
Arantxa Rodríguez-CasadoIMDEA Food Institute, Pabellón Central del Antiguo Hospital de Cantoblanco (Edificio no 7), Crta. de Cantoblanco no 8, 28049, Madrid, Spain.
María TaberneroDepartment of Experimental Surgery, Research Institute Hospital La Paz (IdiPAZ), Paseo de la Castellana 261, 28046, Madrid, Spain.
Alejandro Ruiz-RodríguezDepartment of Production and Characterization of Novel Foods, CIAL - Research Institute in Food Science (UAM+CSIC), Universidad Autónoma de Madrid, C/Nicolas Cabrera 9, Campus de Cantoblanco, 28049, Madrid, Spain.
Guillermo RegleroDepartment of Production and Characterization of Novel Foods, CIAL - Research Institute in Food Science (UAM+CSIC), Universidad Autónoma de Madrid, C/Nicolas Cabrera 9, Campus de Cantoblanco, 28049, Madrid, Spain.
Cristina Soler-RivasDepartment of Production and Characterization of Novel Foods, CIAL - Research Institute in Food Science (UAM+CSIC), Universidad Autónoma de Madrid, C/Nicolas Cabrera 9, Campus de Cantoblanco, 28049, Madrid, Spain. cristina.soler@uam.es.
Hospital La Paz Institute for Health Research · ESIMDEA Food · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the effect of two extracts obtained from Agaricus bisporus on the mRNA expression of cholesterol-related genes. One of the extracts contained ergosterol and other fungal sterols (SFE) and the other contained β-glucans and fungal sterols (EβG).

methodsFirstly, the dietary mixed micelles (DMMs) generated after in vitro digestion of standards and SFE were applied to Caco2 cells. Then, the lower compartment after a Caco2-transport experiment was applied to HepG2 cells. The mRNA expression was assessed in both cell lines by low-density arrays (LDA). Mice received the extracts, ergosterol or control drugs after 4 weeks of a high-cholesterol diet. The lipid profile of plasma, liver and feces was determined. LDA assays were performed in liver and intestines.

resultsThe DMM fraction of SFE up-regulated the LDLR mRNA expression in Caco2 cells. The lower compartment after Caco2-transport experiments up-regulated LDLR and modulated several other lipid-related genes in HepG2 cells. In mice, SFE decreased TC/HDL ratio and reduced hepatic triglycerides paralleled with down-regulation of Dgat1 expression, while EβG did it without transcriptional changes. Addition of SFE or ergosterol induced in jejunum a similar transcriptional response to simvastatin and ezetimibe; they all down-regulated Srebf2 and Nr1h4 (FXR) genes.

conclusionErgosterol-containing extracts from A. bisporus lowered hepatic triglyceride and modify the mRNA expression of cholesterol-related genes although the transcriptional regulation was unrelated to changes in plasma lipid profile. These extracts may be useful limiting hepatic steatosis and as bioactive ingredients to design novel functional foods preventing lifestyle-related diseases such as non-alcoholic fatty liver disease.

Indexed as

AgaricusAnimalsbeta-GlucansCaco-2 CellsCholesterol, DietaryCholesterol, HDLCholesterol, LDLDiacylglycerol O-AcyltransferaseDiet, High-FatDown-RegulationErgosterolEzetimibeFecesGene Expression RegulationHep G2 CellsHumansbeta-GlucansCholesterol, DietaryCholesterol, HDLCholesterol, LDLDgat1 protein, mouseDiacylglycerol O-AcyltransferaseErgosterolEzetimibeReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearRNA, MessengerSimvastatinSREBF2 protein, humanSrebf2 protein, mouseSterol Regulatory Element Binding Protein 2SterolsTriglyceridesCholesterolErgosterolGene expressionLow-density array (LDA)Supercritical CO2 extractionWhite button mushroom

Identifiers

PMID25948514
OpenAlexW298171742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.